NASDAQ:NEO

NeoGenomics News Headlines

$8.39

-0.50 (-5.62%)

(As of 05/18/2022 04:00 PM ET)

Add

Compare

Today's Range: $8.31
▼
$8.94
50-Day Range: $7.38
▼
$17.90
52-Week Range: $7.26
▼
$54.74

Volume: 1.58 million shs
Average Volume: 1.94 million shs
Market Capitalization: $1.05 billion

P/E Ratio: N/A
Dividend Yield: N/A
Beta: 0.86

Get NeoGenomics News Delivered to You Automatically

Media Mentions By Week

NeoGenomics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NEO
News Sentiment
▼
-0.15

0.25
▲
Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NEO Articles
This Week
▼
3

4
▲
NEO Articles
Average Week

NeoGenomics (NASDAQ:NEO) News Headlines Today

Source

Source	Headline
	NeoGenomics (NEO) Appoints Lynn Tetrault as Interim CEO - StreetInsider.com streetinsider.com - May 16 at 10:03 PM
	NeoGenomics Appoints Lynn Tetrault Interim CEO finance.yahoo.com - May 16 at 7:53 AM
	StockNews.com Upgrades NeoGenomics (NASDAQ:NEO) to "Sell" americanbankingnews.com - May 14 at 3:50 AM
	NeoGenomics Liquid Biopsy Subsidiary Inivata and Collaborators Present New Data Further Validating the Application of its RaDaR(R) MRD and InVisionFirst(R)-Lung Tests at the 2022 ASCO Annual Meeting finance.yahoo.com - May 10 at 10:11 AM
	NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary - Yahoo Finance finance.yahoo.com - May 9 at 2:21 PM
	NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary finance.yahoo.com - May 9 at 8:39 AM
	NeoGenomics (NASDAQ:NEO) Reaches New 52-Week Low at $9.13 americanbankingnews.com - May 8 at 3:02 AM
	NeoGenomics To Participate in the BofA Securities 2022 Healthcare Conference - Benzinga - Benzinga benzinga.com - May 5 at 11:23 PM
	NeoGenomics To Participate in the BofA Securities 2022 Healthcare Conference finance.yahoo.com - May 5 at 6:23 PM
	Investors in NeoGenomics (NASDAQ:NEO) have unfortunately lost 76% over the last year finance.yahoo.com - May 5 at 8:22 AM

	NeoGenomics (NASDAQ:NEO) Rating Increased to Sell at StockNews.com americanbankingnews.com - April 30 at 1:16 AM
	NeoGenomics Now the Least Expensive vs. Binance Coin This Year - Nasdaq nasdaq.com - April 28 at 3:42 PM
	Raymond James Maintains Outperform on NeoGenomics, Lowers Price Target to $15 - Benzinga - Benzinga benzinga.com - April 28 at 10:42 AM
	NeoGenomics, Inc. 2022 Q1 - Results - Earnings Call Presentation seekingalpha.com - April 27 at 2:12 PM
	NeoGenomics Reports Revenue of $117 Million in the First Quarter finance.yahoo.com - April 27 at 7:53 AM
	NeoGenomics (NASDAQ:NEO) Reaches New 1-Year Low at $10.64 americanbankingnews.com - April 27 at 3:26 AM
	Bragar Eagel & Squire, PC Is Investigating NeoGenomics - GlobeNewswire globenewswire.com - April 21 at 8:10 AM
	Earnings Preview: NeoGenomics (NEO) Q1 Earnings Expected to Decline finance.yahoo.com - April 20 at 5:09 PM
	Global Lung Cancer Diagnostics Market to Reach $3.4 Billion by 2026 - Yahoo Finance finance.yahoo.com - April 18 at 10:24 AM
	Raymond James Maintains Outperform on NeoGenomics, Lowers Price Target to $18 - Benzinga benzinga.com - April 18 at 5:23 AM
	Morgan Stanley Maintains Equal-Weight on NeoGenomics, Lowers Price Target to $27 - Benzinga - Benzinga benzinga.com - April 12 at 2:21 PM
	NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR(TM) Assay MRD Assay at AACR 2022 - Yahoo Finance finance.yahoo.com - April 11 at 6:12 PM
	NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR(TM) Assay MRD Assay at AACR 2022 finance.yahoo.com - April 11 at 6:12 PM
	NeoGenomics, Inc. Expands Its Global Strategic Partnership Initiatives with Biognosys AG on Multiple Next Generation Proteomics Solutions Supporting Biopharma R&D finance.yahoo.com - April 11 at 9:39 AM
	NeoGenomics Schedules its First Quarter 2022 Earnings Release for April 27, 2022 finance.yahoo.com - April 8 at 9:02 PM
	Neogenomics: Poor Performance, CEO Departure Create Downward Share Price Spiral - Seeking Alpha seekingalpha.com - April 8 at 4:02 PM
	NEO EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Encourages NeoGenomics, Inc. Investors with Losses to Inquire About Securities Class Action Investigation – NEO - GlobeNewswire globenewswire.com - April 6 at 5:52 PM
	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - - Benzinga benzinga.com - April 6 at 7:51 AM
	ONGOING INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in NeoGenomics, Inc. with Losses o - Benzinga benzinga.com - April 5 at 4:46 PM
	Bragar Eagel & Squire, P.C. Is Investigating Natera, Li-Cycle, Barclays, and NeoGenomics and Encourages I - Benzinga benzinga.com - April 4 at 11:33 PM
	Bragar Eagel & Squire, PC Is Investigating Natera, Li-Cycle, Barclays, and NeoGenomics and Encourages Investors to Contact the Firm - GlobeNewswire globenewswire.com - April 4 at 11:33 PM

	Cancer Diagnostics Market is Expected to Surpass USD 185 Billion by 2026, Assesses DelveInsight - GlobeNewswire globenewswire.com - April 4 at 6:33 PM
	SHAREHOLDER ALERT - Labaton Sucharow Investigating NeoGenomics Inc. - NEO - Benzinga - Benzinga benzinga.com - April 4 at 6:33 PM
	NEO INVESTOR NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages NeoGenomics, Inc. Investors with Losses t - Benzinga benzinga.com - April 4 at 6:33 PM
	NEOGENOMICS ALERT: Bragar Eagel & Squire, P.C. is Investigating NeoGenomics, Inc. on Behalf of NeoGenomics Stockholders and Encourages Investors to Contact the Firm - Business Wire businesswire.com - April 2 at 4:32 AM
	Biognosys Presenting Data on its TrueDiscovery™ and TrueTarget™ Proteomics Platforms at the AACR Annual Meeting 2022 - Business Wire businesswire.com - April 1 at 3:48 AM
	Lost Money in NeoGenomics, Inc.? - Business Wire businesswire.com - April 1 at 3:48 AM
	ONGOING INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in NeoGenomics, Inc. with Losses of - Benzinga benzinga.com - March 31 at 5:14 PM
	Investigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of NeoGenomics, Inc. (NASDAQ: NEO) Investors benzinga.com - March 30 at 6:48 PM
	INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in NeoGenomics, Inc. with Losses of $100,0 - Benzinga benzinga.com - March 30 at 4:11 PM
	NeoGenomics Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at NeoGenomics, Inc. - Ben - Benzinga benzinga.com - March 30 at 10:00 AM
	Mid-Afternoon Market Update: Dow Surges 250 Points; NeoGenomics Shares Slide - Benzinga - Benzinga benzinga.com - March 29 at 11:57 PM
	Mid-Afternoon Market Update: Dow Surges 250 Points; NeoGenomics Shares Slide - Benzinga - Benzinga benzinga.com - March 29 at 11:57 PM
	B of A Securities Downgrades NeoGenomics to Neutral, Lowers Price Target to $18 - Benzinga - Benzinga benzinga.com - March 29 at 6:54 PM
	NeoGenomics Shares Drop 36% After CEO Departure, Guidance, Analysts' Cuts - MarketWatch marketwatch.com - March 29 at 6:54 PM
	NeoGenomics Stock Tanks After CEO Exits Amid Sales, Profitability Maelstrom finance.yahoo.com - March 29 at 6:54 PM
	NeoGenomics, Inc. Investors: Company Investigated by the Portnoy Law Firm benzinga.com - March 29 at 12:52 PM
	Why Is NeoGenomics (NEO) Stock Down Today? investorplace.com - March 29 at 12:02 PM
	UPDATE: Stephens Downgrades Neogenomics (NEO) to Equal Weight - StreetInsider.com streetinsider.com - March 29 at 8:38 AM
	The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, - Benzinga benzinga.com - March 29 at 8:38 AM

Get NeoGenomics News Delivered to You Automatically

This page was last updated on 5/19/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources